GGT5 heavy chain Polyclonal Antibody, Cy3 Conjugated
Applications
Predicted Reactivity
| Overview | |
| Catalog # | bs-13349R-Cy3 |
| Product Name | GGT5 heavy chain Polyclonal Antibody, Cy3 Conjugated |
| Applications |
WB
IF(IHC-P)
IF(IHC-F)
IF(ICC)
|
| Predicted Reactivity | Human, Mouse, Rat, Cow, Sheep, Horse, Rabbit |
| Specifications | |
| Conjugation | Cy3 |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human Gamma-glutamyltransferase 5 heavy chain |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1ug/ul |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 2687 |
| Swiss Prot | P36269 |
| Subcellular location | Cell membrane |
| Synonyms | Gamma glutamyl transpeptidase related enzyme; Gamma glutamyltranspeptidase 5; Gamma-glutamyl transpeptidase-related enzyme; Gamma-glutamyltransferase 5 heavy chain; Gamma-glutamyltransferase-like activity 1; Gamma-glutamyltranspeptidase 5; GGT 5; GGT REL; GGT-rel; GGT5; GGT5_HUMAN; DKFZP566O011; GGTLA1; Glutathione hydrolase 5; Leukotriene-C4 hydrolase; Gamma-glutamyltransferase 5 heavy chain. |
| Background | g-glutamyltranspeptidase (GGT) acts as a glutathionase and catalyzes the transfer of the glutamyl moiety of Glutathione to a variety of amino acids and dipeptide acceptors. This enzyme is located on the outer surface of the cell membrane and is widely distributed in mammalian tissues involved in absorption and secretion. In humans, hepatic GGT activity is elevated in some liver diseases. GGT1 is released into the bloodstream after liver damage and an elevated level of the enzyme may be a useful early sign of hepatocellular carcinoma. GGT5 converts Leukotriene C4 to Leukotriene D4; it does not, however, convert synthetic substrates that are commonly used to assay GGT. In human serum and tissues there is a marked heterogeneity in GGT, but this heterogeneity can be attributed to different glycosylation of the same peptide rather than to the products of different genes. |
| Application Dilution | |
| WB | 1:300-5000 |
| IF(IHC-P) | 1:50-200 |
| IF(IHC-F) | 1:50-200 |
| IF(ICC) | 1:50-200 |
Frequently asked questions
Which applications is GGT5 heavy chain Polyclonal Antibody, Cy3 Conjugated (bs-13349R-Cy3) validated for, and at what dilution?
bs-13349R-Cy3 is validated for WB (1:300-5000); IF(IHC-P) (1:50-200); IF(IHC-F) (1:50-200); IF(ICC) (1:50-200). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
How should bs-13349R-Cy3 be stored?
Store at -20C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. Storage buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise GGT5 heavy chain Polyclonal Antibody, Cy3 Conjugated (bs-13349R-Cy3)?
KLH conjugated synthetic peptide derived from human Gamma-glutamyltransferase 5 heavy chain
What are the excitation and emission wavelengths of the Cy3 conjugate (bs-13349R-Cy3)?
Cy3 on bs-13349R-Cy3: excitation / emission 512,550nm/570,615nm.